New Risk • Jul 09
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (8.7% average weekly change). Reported Earnings • May 20
First quarter 2026 earnings released: EPS: €0.10 (vs €0.05 in 1Q 2025) First quarter 2026 results: EPS: €0.10 (up from €0.05 in 1Q 2025). Revenue: €300.2m (down 13% from 1Q 2025). Net income: €3.90m (up 106% from 1Q 2025). Profit margin: 1.3% (up from 0.5% in 1Q 2025). Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Announcement • Apr 17
H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026 H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2026, at 10:00 W. Europe Standard Time. Announcement • Apr 17
H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 H&R GmbH & Co. KGaA announced Annual dividend of EUR 0.1000 per share payable on May 30, 2025, ex-date on May 28, 2025 and record date on May 29, 2025. Announcement • Apr 16
H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025 H&R GmbH & Co. KGaA, Annual General Meeting, May 27, 2025, at 10:00 W. Europe Standard Time. Reported Earnings • Nov 17
Third quarter 2024 earnings released: EPS: €0.09 (vs €0.20 in 3Q 2023) Third quarter 2024 results: EPS: €0.09 (down from €0.20 in 3Q 2023). Revenue: €348.7m (up 3.4% from 3Q 2023). Net income: €3.52m (down 54% from 3Q 2023). Profit margin: 1.0% (down from 2.2% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. Reported Earnings • Aug 16
Second quarter 2024 earnings released: EPS: €0.03 (vs €0.13 in 2Q 2023) Second quarter 2024 results: EPS: €0.03 (down from €0.13 in 2Q 2023). Revenue: €347.5m (flat on 2Q 2023). Net income: €1.30m (down 72% from 2Q 2023). Profit margin: 0.4% (down from 1.3% in 2Q 2023). Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 26% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €4.05, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in Germany. Total loss to shareholders of 56% over the past three years. Upcoming Dividend • May 22
Upcoming dividend of €0.10 per share Eligible shareholders must have bought the stock before 29 May 2024. Payment date: 31 May 2024. Payout ratio is a comfortable 30% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%). Reported Earnings • May 17
First quarter 2024 earnings released: EPS: €0.04 (vs €0.03 loss in 1Q 2023) First quarter 2024 results: EPS: €0.04 (up from €0.03 loss in 1Q 2023). Revenue: €343.7m (down 1.5% from 1Q 2023). Net income: €1.47m (up €2.42m from 1Q 2023). Profit margin: 0.4% (up from net loss in 1Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 8.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 30
Full year 2023 earnings: EPS and revenues miss analyst expectations Full year 2023 results: EPS: €0.28 (down from €1.15 in FY 2022). Revenue: €1.35b (down 15% from FY 2022). Net income: €10.6m (down 75% from FY 2022). Profit margin: 0.8% (down from 2.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 4.0%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Declared Dividend • Mar 30
Dividend of €0.10 announced Dividend of €0.10 is the same as last year. Ex-date: 29th May 2024 Payment date: 31st May 2024 Dividend yield will be 2.1%, which is lower than the industry average of 6.1%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (4% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 53% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 18
Second quarter 2023 earnings released: EPS: €0.13 (vs €0.58 in 2Q 2022) Second quarter 2023 results: EPS: €0.13 (down from €0.58 in 2Q 2022). Revenue: €358.1m (down 19% from 2Q 2022). Net income: €4.69m (down 78% from 2Q 2022). Profit margin: 1.3% (down from 4.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings. Upcoming Dividend • May 17
Upcoming dividend of €0.10 per share at 1.9% yield Eligible shareholders must have bought the stock before 24 May 2023. Payment date: 26 May 2023. Trailing yield: 1.9%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%). Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €5.10, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Germany. Total returns to shareholders of 21% over the past three years. Buying Opportunity • Apr 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 2.5%. The fair value is estimated to be €7.73, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to decline by 12% in 2 years. Earnings is forecast to decline by 64% in the next 2 years. Reported Earnings • Apr 02
Full year 2022 earnings: EPS exceeds analyst expectations Full year 2022 results: EPS: €1.15 (down from €1.35 in FY 2021). Revenue: €1.58b (up 32% from FY 2021). Net income: €42.7m (down 15% from FY 2021). Profit margin: 2.7% (down from 4.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%. Revenue is expected to decline by 6.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Germany are expected to grow by 1.8%. Over the last 3 years on average, earnings per share has increased by 88% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Mar 01
Now 22% undervalued after recent price drop Over the last 90 days, the stock is down 3.6%. The fair value is estimated to be €7.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years. Buying Opportunity • Feb 14
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 7.3%. The fair value is estimated to be €7.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years. Buying Opportunity • Jan 25
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 8.5%. The fair value is estimated to be €7.57, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 92%. Revenue is forecast to decline by 9.5% in 2 years. Earnings is forecast to decline by 65% in the next 2 years. Price Target Changed • Nov 16
Price target decreased to €6.50 Down from €7.25, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of €6.52. Stock is down 21% over the past year. The company is forecast to post earnings per share of €1.01 for next year compared to €1.35 last year. Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment improved over the past week After last week's 16% share price gain to €6.48, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 10x in the Chemicals industry in Germany. Total returns to shareholders of 8.0% over the past three years. Reported Earnings • Aug 17
Second quarter 2022 earnings released: EPS: €0.58 (vs €0.64 in 2Q 2021) Second quarter 2022 results: EPS: €0.58 (down from €0.64 in 2Q 2021). Revenue: €453.6m (up 43% from 2Q 2021). Net income: €21.6m (down 8.8% from 2Q 2021). Profit margin: 4.8% (down from 7.5% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 2.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • May 16
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: €0.22 (up from €0.19 in 1Q 2021). Revenue: €368.8m (up 53% from 1Q 2021). Net income: €8.09m (up 12% from 1Q 2021). Profit margin: 2.2% (down from 3.0% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 6.7%, compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Price Target Changed • Apr 27
Price target decreased to €7.25 Down from €8.25, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €6.00. Stock is down 18% over the past year. The company is forecast to post earnings per share of €0.48 for next year compared to €1.35 last year. Reported Earnings • Apr 01
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: €1.35 (up from €0.24 loss in FY 2020). Revenue: €1.19b (up 35% from FY 2020). Net income: €50.2m (up €59.2m from FY 2020). Profit margin: 4.2% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) also surpassed analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 1.8%, compared to a 7.6% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 17
Third quarter 2021 earnings released: EPS €0.43 (vs €0.03 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €325.2m (up 56% from 3Q 2020). Net income: €16.0m (up €17.3m from 3Q 2020). Profit margin: 4.9% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 4% per year. Reported Earnings • May 17
First quarter 2021 earnings released: EPS €0.19 (vs €0.13 loss in 1Q 2020) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: €248.5m (down 4.2% from 1Q 2020). Net income: €7.24m (up €12.0m from 1Q 2020). Profit margin: 2.9% (up from net loss in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 24
Full year 2020 earnings released: €0.24 loss per share (vs €0.037 loss in FY 2019) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: €878.5m (down 19% from FY 2019). Net loss: €9.02m (loss widened €7.65m from FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance. Price Target Changed • Feb 02
Price target raised to €6.65 Up from €5.90, the current price target is an average from 2 analysts. The new target price is 11% above the current share price of €6.00. As of last close, the stock is up 14% over the past year. Is New 90 Day High Low • Jan 08
New 90-day high: €5.85 The company is up 19% from its price of €4.91 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.10 per share. Is New 90 Day High Low • Nov 28
New 90-day high: €5.77 The company is up 11% from its price of €5.22 on 28 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.40 per share. Analyst Estimate Surprise Post Earnings • Nov 17
Revenue and earnings miss expectations Revenue missed analyst estimates by 16%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to grow 5.7%, compared to a 3.6% growth forecast for the Chemicals industry in Germany. Reported Earnings • Nov 17
Third quarter 2020 earnings released: €0.03 loss per share The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2020 results: Revenue: €213.3m (down 22% from 3Q 2019). Net loss: €1.21m (loss narrowed 80% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 31% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Oct 15
New 90-day low: €4.87 The company is down 18% from its price of €5.95 on 17 July 2020. The German market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.47 per share. Announcement • Oct 05
H&R Wasag AG to Report Q3, 2010 Results on 11/12/2010 H&R Wasag AG announced that they will report Q3, 2010 results on 11/12/2010 Is New 90 Day High Low • Sep 26
New 90-day low: €5.12 The company is down 4.0% from its price of €5.31 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.43 per share.